KCT0008889
Completed
未知
Management of temporomandibular disorder through self-monitoring application use and cognitive behavioral therapy for temporomandibular disorder patients and evaluation of symptom improvement effect : Pilot study
ConditionsDiseases of the digestive system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the digestive system
- Sponsor
- Seoul National University Bundang Hospital
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •? Adults aged 19 to 65 years old.
- •? Patients diagnosed with temporomandibular disorder (TMD) who visited the Seoul National University Dental Hospital.
- •? Patients diagnosed with muscular disorders, temporomandibular joint internal derangements, and temporomandibular joint arthritis based on clinical and radiological examinations.
- •? Individuals who voluntarily decided to participate in this clinical trial and provided written consent.
Exclusion Criteria
- •? Individuals not diagnosed with temporomandibular disorder (TMD) based on clinical and radiological examinations.
- •? Individuals with intrinsic diseases of the temporomandibular joint: ankylosis, tumors.
- •? Individuals with traumatic conditions of the temporomandibular joint: mandibular condyle fractures, major facial trauma (e.g., from traffic accidents, assaults, etc.).
- •? Individuals suffering from rare muscular diseases such as severe myasthenia gravis, Eaton\-Lambert syndrome, and amyotrophic lateral sclerosis.
- •? Individuals with serious metabolic diseases like severe hypertension or diabetes.
- •? Individuals diagnosed with neurological disorders (e.g., Parkinson's, Alzheimer's) or psychiatric disorders.
- •? Individuals currently taking medications for sleep disorders (e.g., benzodiazepines, muscle relaxants, tricyclic antidepressants, etc.), or potentially consuming unauthorized drugs, alcohol, or narcotics.
- •? Individuals undergoing dental orthodontics or wearing other oral devices.
- •? Cases where the participant withdraws their consent.
- •? Any other individuals deemed inappropriate for the study by the principal investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Treatment of TMJ disorder using autologous ADSCs (AUASC-TKY2017)Refractory emporomandibular joint disorder with the symptoms of osteoarthritis (pain and/or trismus)JPRN-jRCTb030190134Hoshi Kazuto3
Active, not recruiting
Phase 3
MiTiGate trial: Is Botox more effective than lidocaine and treatment as usual in myalgia temporomandibular disorder (TMD)?Myalgia temporomandibular disorder (M TMD)Musculoskeletal DiseasesISRCTN12054536ewcastle upon Tyne Hospitals NHS Foundation Trust663
Unknown
Phase 2
Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective StudyTemporo-Myofascial DisorderNCT02810015University of Manitoba40
Not yet recruiting
Not Applicable
Effect of Bioxidative Ozone therapy vs Double Needle Arthrocentesis in Temporomandibular Joint Disorders.CTRI/2023/09/057512ONE
Recruiting
Not Applicable
Treatment of Temporomandibular Joint Problems with Laser Therapy and Occlusal SplintTemporomandibular Joint Dysfunction SyndromeFacial PainC05.500.607.221.897.897C10.597.617.203RBR-5mgv4kniversidade Federal de Santa Maria